Related Experiment Video
Updated: Feb 13, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Prevention of Contrast-Induced Acute Kidney Injury: an Update
George Chalikias1, Ioannis Drosos2, Dimitrios N Tziakas3
1University Cardiology Department, Medical School, Democritus University of Thrace, Dragana, 68131, Alexandroupolis, Greece.
Insights
Preventing contrast-induced acute kidney injury (CI-AKI) involves hydration and potential pharmacologic agents like statins and N-acetylcysteine. This review summarizes evidence from meta-analyses on CI-AKI prevention strategies.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced acute kidney injury (CI-AKI) is a frequent complication following intravascular contrast media administration.
- Procedures like coronary angiography and percutaneous coronary intervention carry a risk of CI-AKI.
Purpose of the Study:
- To review and summarize high-quality meta-analyses on preventing CI-AKI.
- To critically appraise available data and clinical guidelines for CI-AKI prevention.
Main Methods:
- Literature search focusing on high-quality meta-analyses.
- Synthesis of published data on CI-AKI prevention strategies.
- Critical clinical appraisal of evidence.
Main Results:
- Adequate hydration is a primary preventive measure.
- Pharmacologic agents, notably statins and N-acetylcysteine, are extensively studied for CI-AKI prevention.
- Evidence from meta-analyses guides the selection of preventive strategies.
Conclusions:
- Hydration remains crucial for CI-AKI prevention.
- Statins and N-acetylcysteine show promise but require careful consideration within clinical practice.
- Guidelines for CI-AKI prevention should incorporate the latest evidence from meta-analyses.
Abstract:
Contrast-induced acute kidney injury (CI-AKI) is a common complication of intravascular administration of contrast media used in coronary angiography, percutaneous coronary intervention and other diagnostic and interventional procedures. This review article aims at summarizing the published literature regarding the prevention of CI-AKI, by focusing on available high-quality meta-analyses addressing this matter. Apart from adequate hydration, a number of pharmacologic agents have been proposed as potential candidates to be included in the routine preparation, prior to the patient's arrival in the cardiac catheterization laboratory. Among them, statins and N-acetylcysteine appear to be the most extensively studied ones. Throughout this article we present the available data on CI-AKI prevention and provide a critical clinical appraisal, as well as a summary of currently available guidelines.
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction

